Total Payments
$128,475
2024 Payments
$55,134
Companies
31
Transactions
448
Medicare Patients
3,275
Medicare Billing
$362,417
Payment Breakdown by Category
Other$97,745 (76.1%)
Food & Beverage$11,664 (9.1%)
Consulting$10,850 (8.4%)
Travel$7,986 (6.2%)
Education$230.54 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $97,745 | 45 | 76.1% |
| Food and Beverage | $11,664 | 361 | 9.1% |
| Consulting Fee | $10,850 | 3 | 8.4% |
| Travel and Lodging | $7,986 | 35 | 6.2% |
| Education | $230.54 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $58,076 | 106 | $0 (2024) |
| United Therapeutics Corporation | $50,838 | 92 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $15,064 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,096 | 69 | $0 (2023) |
| Genentech USA, Inc. | $560.93 | 20 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $479.08 | 23 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $411.59 | 27 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $292.07 | 16 | $0 (2020) |
| Mylan Specialty L.P. | $255.11 | 15 | $0 (2020) |
| Merck Sharp & Dohme LLC | $192.35 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $55,134 | 86 | United Therapeutics Corporation ($28,526) |
| 2023 | $44,007 | 71 | United Therapeutics Corporation ($17,403) |
| 2022 | $19,626 | 36 | Actelion Pharmaceuticals US, Inc. ($14,573) |
| 2021 | $378.29 | 6 | Actelion Pharmaceuticals US, Inc. ($262.67) |
| 2020 | $267.17 | 17 | GlaxoSmithKline, LLC. ($49.70) |
| 2019 | $1,262 | 77 | GlaxoSmithKline, LLC. ($237.18) |
| 2018 | $1,500 | 80 | GlaxoSmithKline, LLC. ($327.42) |
| 2017 | $6,301 | 75 | Actelion Pharmaceuticals US, Inc. ($5,170) |
All Payment Transactions
448 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $39.23 | General |
| Category: Cardiology | ||||||
| 12/17/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: Cardiology | ||||||
| 12/16/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Cardiology | ||||||
| 12/10/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $75.00 | General |
| 12/04/2024 | United Therapeutics Corporation | TYVASO (Drug), REMODULIN, ORENITRAM | Food and Beverage | In-kind items and services | $92.47 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/11/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | United Therapeutics Corporation | Steen Solution (Device), REMODULIN | Food and Beverage | In-kind items and services | $82.50 | General |
| Category: Lung Transplant | ||||||
| 10/22/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/17/2024 | United Therapeutics Corporation | TYVASO (Drug) | Travel and Lodging | Cash or cash equivalent | $152.76 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/16/2024 | United Therapeutics Corporation | TYVASO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,460.00 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/15/2024 | United Therapeutics Corporation | TYVASO (Drug), ORENITRAM, REMODULIN | Food and Beverage | In-kind items and services | $78.94 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 09/20/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $420.00 | General |
| Category: Cardiology | ||||||
| 09/17/2024 | United Therapeutics Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| 09/17/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Cardiology | ||||||
| 09/16/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $2.33 | General |
| Category: Cardiology | ||||||
| 09/03/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $113.64 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 08/06/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Travel and Lodging | Cash or cash equivalent | $129.98 | General |
| Category: Cardiology | ||||||
| 07/31/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,940.00 | General |
| Category: Cardiology | ||||||
| 07/29/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $123.05 | General |
| Category: Cardiology | ||||||
| 07/23/2024 | United Therapeutics Corporation | TYVASO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 06/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,888.00 | General |
| Category: Cardio-pulmonary | ||||||
| 06/21/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: Cardiology | ||||||
| 06/19/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $123.94 | General |
| Category: Cardiology | ||||||
| 06/18/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $122.88 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,011 | 1,353 | $293,792 | $104,469 |
| 2022 | 12 | 814 | 1,170 | $249,072 | $91,822 |
| 2021 | 15 | 666 | 935 | $224,390 | $83,969 |
| 2020 | 15 | 784 | 948 | $243,625 | $82,157 |
Total Patients
3,275
Total Services
4,406
Medicare Billing
$362,417
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 171 | 286 | $66,842 | $26,206 | 39.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 89 | 177 | $38,940 | $16,246 | 41.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 78 | 108 | $35,220 | $14,596 | 41.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 39 | 76 | $47,576 | $12,516 | 26.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 145 | 169 | $17,745 | $6,976 | 39.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 49 | 50 | $15,500 | $5,090 | 32.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 135 | 155 | $18,290 | $4,403 | 24.1% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 83 | 98 | $9,996 | $3,924 | 39.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $10,672 | $3,621 | 33.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 22 | $10,032 | $2,989 | 29.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $8,808 | $2,835 | 32.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 67 | 71 | $5,822 | $2,322 | 39.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 23 | $3,450 | $1,425 | 41.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 66 | 71 | $4,899 | $1,319 | 26.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 131 | 285 | $61,185 | $22,713 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 219 | $46,800 | $20,885 | 44.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 34 | 73 | $44,719 | $12,472 | 27.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 70 | 72 | $21,336 | $7,616 | 35.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 53 | 53 | $17,994 | $6,673 | 37.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 29 | 39 | $11,709 | $5,468 | 46.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 89 | 104 | $10,920 | $4,580 | 41.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 40 | 60 | $8,848 | $3,353 | 37.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 85 | 99 | $11,682 | $2,892 | 24.8% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 50 | 53 | $5,406 | $2,260 | 41.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 47 | 52 | $4,264 | $1,728 | 40.5% |
About Dr. Benjamin Wind, DO
Dr. Benjamin Wind, DO is a Internal Medicine healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831279488.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Wind, DO has received a total of $128,475 in payments from pharmaceutical and medical device companies, with $55,134 received in 2024. These payments were reported across 448 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($97,745).
As a Medicare-enrolled provider, Wind has provided services to 3,275 Medicare beneficiaries, totaling 4,406 services with total Medicare billing of $362,417. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease, Critical Care Medicine
- Location Philadelphia, PA
- Active Since 10/17/2006
- Last Updated 06/01/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1831279488
Products in Payments
- UPTRAVI (Drug) $49,835
- Adempas (Drug) $14,942
- TYVASO (Drug) $13,272
- OPSUMIT MACITENTAN (Drug) $5,154
- OPSUMIT (Drug) $2,871
- XOLAIR (Biological) $292.07
- ANORO (Drug) $262.98
- TRELEGY ELLIPTA (Drug) $255.76
- ORENITRAM (Drug) $247.81
- BREO (Drug) $226.57
- Esbriet (Biological) $183.16
- Steen Solution (Device) $180.50
- BEVESPI AEROSPHERE (Drug) $177.24
- WINREVAIR (Biological) $166.65
- STIOLTO (Drug) $164.15
- Yupelri (Drug) $147.93
- CHARTIS CATHETER (Device) $142.56
- NUCALA (Biological) $140.40
- Xolair (Biological) $132.78
- FASENRA (Drug) $130.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Philadelphia
Pitamber Devgon, Md, MD
Internal Medicine — Payments: $7.5M
Internal Medicine $7.5M
Dr. David Horn, M.d, M.D
Internal Medicine — Payments: $1.7M
Internal Medicine $1.7M
Daniel Rader, Md, MD
Internal Medicine — Payments: $1.6M
Internal Medicine $1.6M
Corey Langer, Md, MD
Internal Medicine — Payments: $742,647
Internal Medicine $742,647
Dr. Intekhab Ahmed, M.d, M.D
Internal Medicine — Payments: $621,997
Internal Medicine $621,997
David Goldmann, Md, MD
Internal Medicine — Payments: $587,696
Internal Medicine $587,696